logo
Sections

Latest trends

Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention
Reinhold Kreutz
Pol Arch Intern Med. 2024, Vol. 134, No. 11: 16892; DOI: 10.20452/pamw.16892
Cardiovascular abnormalities in patients with acute intermittent porphyria: the AIPRACUS study
Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Andrzej Januszewicz, Hanna Szwed, Rafał Dąbrowski
Pol Arch Intern Med. 2024, Vol. 134, No. 7-8: 16820; DOI: 10.20452/pamw.16820
Aprocitentan: a novel option for treatment of resistant arterial hypertension
Krzysztof Narkiewicz
Pol Arch Intern Med. 2024, Vol. 134, No. 5: 16764; DOI: 10.20452/pamw.16764
Impact of malignant hypertension on cardiovascular risk and organ damage: what can we learn from the French HAMA registry?
Andrzej Januszewicz, Mateusz Śpiewak, Romain Boulestreau
Pol Arch Intern Med. 2024, Vol. 134, No. 2: 16690; DOI: 10.20452/pamw.16690